https://synapse.patsnap.com/drug/9c20284337b04407819cecc2a3ce7809
Erbitux-MHT-71 - Drug Targets, Indications, Patents - Synapse
drug targetserbituxmhtindicationspatents
https://www.biocentury.com/article/193630/erbitux-cetuximab-phase-i-ii-data
BioCentury - Erbitux cetuximab: Phase I/II data
Data from a Phase I/II trial in 21 patients showed that first-line treatment with Erbitux plus irinotecan-based chemotherapy caused a median survival of 33...
phase ierbituxiidata
https://biovoicenews.com/enzene-biosciences-launches-cetuximab-the-first-biosimilar-of-cancer-treatment-drug-erbitux/
Enzene Biosciences launches Cetuximab: the first biosimilar of cancer treatment drug Erbitux -...
Jun 9, 2023 - Cetuximab is the first biosimilar in the world, of cancer treatment drug Erbitux
the firstcancer treatmentbioscienceslaunchesbiosimilar
https://www.sydlabs.com/erbitux-biosimilar-stable-cell-line.html
erbitux biosimilar stable cell line Products - Syd Labs
erbitux biosimilar stable cell line products for sale, more erbitux biosimilar stable cell line related products under development. We have always tried our...
cell lineerbituxbiosimilarstableproducts
https://researchoutput.ncku.edu.tw/en/publications/a-postmarketing-surveillance-study-on-erbitux-cetuximab-in-patien/
A postmarketing surveillance study on erbitux (cetuximab) in patients with metastatic colorectal...
in patientssurveillancestudyerbituxmetastatic
https://www.milanmedicals.com/product-tag/erbitux-cetuximab/
Erbitux Cetuximab - Milan Medicals
erbituxmilanmedicals